Skip to content

Targeted Medical Pharma, Inc.

company.status.inactive

CIK 1420030fmd_1W0FA2ER5Y7FRY5564D6S738A2Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2010 to Dec 31, 2015, 23 periods

Income Statement · Annual · Millions · USD
Line itemFY2011FY2012FY2013FY2014FY2015FY2016
Total revenues8971075
Cost of revenue333322
Gross profit564753
Research and development000000
Selling, general and administrative612101075
Total operating expenses712101085
Operating income(2)(6)(6)(4)(3)(2)
Interest expense––2(0)––
Other non-operating income (expense)1(1)(7)0(1)(1)
Income before taxes(1)(7)(13)(4)(4)(3)
Income tax expense–(2)(3)60–
Net income from continuing operations–(4)(10)(9)(4)–
Net income(1)(4)(10)(9)(4)(3)
Targeted Medical Pharma, Inc. financial statements · FinancialMD